Logo image of NPCE

NEUROPACE INC (NPCE) Stock Overview

USA - NASDAQ:NPCE - US6412881053 - Common Stock

10.2 USD
+0.19 (+1.9%)
Last: 9/26/2025, 8:16:57 PM
10 USD
-0.2 (-1.96%)
After Hours: 9/26/2025, 8:16:57 PM

NPCE Key Statistics, Chart & Performance

Key Statistics
52 Week High18.98
52 Week Low5.45
Market Cap337.42M
Shares33.08M
Float25.14M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.84
PEN/A
Fwd PEN/A
Earnings (Next)11-10 2025-11-10/amc
IPO04-22 2021-04-22
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


NPCE short term performance overview.The bars show the price performance of NPCE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5 10 -10

NPCE long term performance overview.The bars show the price performance of NPCE in the last 1, 2 and 3 years. 1 year 2 years 3 years 50 100 150

The current stock price of NPCE is 10.2 USD. In the past month the price increased by 11.96%. In the past year, price increased by 52.69%.

NEUROPACE INC / NPCE Daily stock chart

NPCE Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 27.26 232.44B
ISRG INTUITIVE SURGICAL INC 54.8 158.13B
BSX BOSTON SCIENTIFIC CORP 34.69 145.48B
SYK STRYKER CORP 28.72 141.08B
MDT MEDTRONIC PLC 17.04 120.86B
BDX BECTON DICKINSON AND CO 12.94 52.91B
IDXX IDEXX LABORATORIES INC 52.64 50.58B
EW EDWARDS LIFESCIENCES CORP 29.67 44.77B
RMD RESMED INC 28.3 39.57B
GEHC GE HEALTHCARE TECHNOLOGY 15.55 33.08B
DXCM DEXCOM INC 39.47 26.31B
PHG KONINKLIJKE PHILIPS NVR- NY 15.87 25.83B

About NPCE

Company Profile

NPCE logo image NeuroPace, Inc. develops, manufactures, and markets implantable devices for treating epilepsy and neurological disorders. The company is headquartered in Mountain View, California and currently employs 209 full-time employees. The company went IPO on 2021-04-22. The firm is focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. The firm has developed its RNS System to address the individualized nature of drug-resistant epilepsy and deliver a safe therapy for focal onset seizures anywhere in the brain. The RNS System is a device that records brain activity data and allows clinicians to monitor patients not only in person, but also remotely. The RNS System monitors and analyzes the brain’s electrical activity, recognizes patient-specific abnormal patterns, and delivers treatment at the seizure source. The Company’s RNS System is also engaged in treating other brain disorders, including depression, impulse control disorders, memory disorders, and post-traumatic stress disorders.

Company Info

NEUROPACE INC

455 N. Bernardo Avenue

Mountain View CALIFORNIA US

CEO: Michael Favet

Employees: 209

NPCE Company Website

NPCE Investor Relations

Phone: 16502372700

NEUROPACE INC / NPCE FAQ

What is the stock price of NEUROPACE INC today?

The current stock price of NPCE is 10.2 USD. The price increased by 1.9% in the last trading session.


What is the ticker symbol for NEUROPACE INC stock?

The exchange symbol of NEUROPACE INC is NPCE and it is listed on the Nasdaq exchange.


On which exchange is NPCE stock listed?

NPCE stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for NEUROPACE INC stock?

14 analysts have analysed NPCE and the average price target is 17.19 USD. This implies a price increase of 68.57% is expected in the next year compared to the current price of 10.2. Check the NEUROPACE INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is NEUROPACE INC worth?

NEUROPACE INC (NPCE) has a market capitalization of 337.42M USD. This makes NPCE a Small Cap stock.


How many employees does NEUROPACE INC have?

NEUROPACE INC (NPCE) currently has 209 employees.


What are the support and resistance levels for NEUROPACE INC (NPCE) stock?

NEUROPACE INC (NPCE) has a support level at 10.19 and a resistance level at 10.4. Check the full technical report for a detailed analysis of NPCE support and resistance levels.


Is NEUROPACE INC (NPCE) expected to grow?

The Revenue of NEUROPACE INC (NPCE) is expected to grow by 20.22% in the next year. Check the estimates tab for more information on the NPCE EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy NEUROPACE INC (NPCE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does NEUROPACE INC (NPCE) stock pay dividends?

NPCE does not pay a dividend.


When does NEUROPACE INC (NPCE) report earnings?

NEUROPACE INC (NPCE) will report earnings on 2025-11-10, after the market close.


What is the Price/Earnings (PE) ratio of NEUROPACE INC (NPCE)?

NEUROPACE INC (NPCE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.84).


What is the Short Interest ratio of NEUROPACE INC (NPCE) stock?

The outstanding short interest for NEUROPACE INC (NPCE) is 4% of its float. Check the ownership tab for more information on the NPCE short interest.


NPCE Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to NPCE. When comparing the yearly performance of all stocks, NPCE is one of the better performing stocks in the market, outperforming 82.98% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

NPCE Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to NPCE. Both the profitability and financial health of NPCE have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

NPCE Financial Highlights

Over the last trailing twelve months NPCE reported a non-GAAP Earnings per Share(EPS) of -0.84. The EPS increased by 22.94% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -24.45%
ROE -133.46%
Debt/Equity 3.02
Chartmill High Growth Momentum
EPS Q2Q%0%
Sales Q2Q%22.14%
EPS 1Y (TTM)22.94%
Revenue 1Y (TTM)23.32%

NPCE Forecast & Estimates

14 analysts have analysed NPCE and the average price target is 17.19 USD. This implies a price increase of 68.57% is expected in the next year compared to the current price of 10.2.

For the next year, analysts expect an EPS growth of 8.47% and a revenue growth 20.22% for NPCE


Analysts
Analysts84.29
Price Target17.19 (68.53%)
EPS Next Y8.47%
Revenue Next Year20.22%

NPCE Ownership

Ownership
Inst Owners60.77%
Ins Owners2.49%
Short Float %4%
Short Ratio5.02